A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive

Trial Identifier:	219728
Sponsor:	GlaxoSmithKline
Start Date:	June 2024
Primary Completion Date:	October 2024
Study Completion Date:	October 2024
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Netherlands	Groningen, Netherlands, 9728

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.